We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Improving Lung Cancer Survival and Alleviating Chemotherapy-induced Neutropenia
Blog

We recently spoke with Dr Lan Huang, CEO at BeyondSpring, a clinical-stage biopharmaceutical company to learn more about the company’s efforts to develop innovative immuno-oncology cancer therapies.

Read More

Measuring the Dose and Spread of Radiation Delivered to the Site of a Tumor
Blog

We recently had the pleasure of interviewing award-winning medical physicist Shakar Jafari, PhD. Shakar tells us about her scientific background, her pioneering research exploring the properties of glass bead detectors for measuring radiation, and how this technology could dramatically improve the accuracy of cancer treatment.

Read More

Releasing the Handbrake on Exosome Applications
Blog

Despite the great excitement about exosomes and their huge diagnostic and therapeutic potential, the technology needed to advance this work is lacking. We spoke to Jim West, CEO of Clara Biotech, who tells us how his team is working to fill that gap.

Read More

Proteogenomics, Precision Medicine and Oncology
Blog

Major advances have occurred in the fields of proteomics and genomics over recent years. Now, scientists are utilizing the technologies from each approach collectively in a novel research area named proteogenomics. We spoke with Alexzander Asea, Professor and Director at Precision Therapeutics Proteogenomics Diagnostics Center, University of Toledo, to learn more about the applications of proteogenomics in precision medicine.

Read More

Keeping Cell and Gene Therapies Alive in Transit
Blog

Cryoport is the single largest cryogenic delivery system for immunotherapy drugs, and the sole cryogenics logistics provider for the first two commercialized cell therapies. To learn more about the company providing the logistics backbone of clinical trials for regenerative medicine, we caught up with Mark Sawicki, chief commercial officer.

Read More

Take a Good Book Around
Blog

Our recent social media poll on "book recommendations for scientists" provided an incredible response. We decided to collate this information and give you the perfect excuse to treat yourself to a new read. Enjoy!

Read More

Breath Test for Cancer: Biomarker Screening is Underway
Blog

The thought that compounds in the breath could be measured and assessed to diagnose different aspects of pathology is an exciting prospect. To learn more about the breathalyzer platform being used in clinical trials to detect early cancer biomarkers, we spoke to Chris Claxton, head of investor relations at Owlstone Medical.

Read More

Superficial Radiation Therapy: A Non-surgical Treatment for Non-melanoma Skin Cancers
Blog

Skin cancer can be broadly split in to two types: melanoma and non-melanoma. The most common non-melanomas include basal cell carcinoma and squamous cell carcinoma, for which the main treatment is surgery. However, other non-surgical options are emerging, including superficial radiation therapy (SRT), a unique type of photon radiotherapy.

Read More

The Vision for Multi-organ Human-on-a-Chip Models
Blog

The development of organ-on-a-chip models aims to reduce the (expensive) high drug failure rates that exist in clinical trials. A Florida biotech firm recently reported that their multi-organ “human-on-a-chip” system maintains cellular viability over 28 days in serum-free conditions, using a pumpless system. To learn more about the vision for multi-organ “human-on-a-chip” models, we caught up with James Hickman, Chief Science Officer of Hesperos Inc.

Read More

Is Off-the-Shelf Immunotherapy the Way Forward?
Blog

An “off-the-shelf” immuno-oncology product has been developed whereby T cells are derived from healthy donors, bypassing limitations related to high pricing and limited market access.

Read More